| Company/Division name | OSANG Healthcare Co., Ltd. |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Country(ies) from which reshored: | Korea, Republic of |
| City reshored to: | San Diego |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | GeneFinder(R) COVID-19 Plus RealAmp Kit, flu test |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training, Other, essential product supply, Covid-19 |
